FDA-approved for the treatment of candidemia and invasive candidiasis, Rezafungin demonstrates strong efficacy against Candida spp., including C
This capacity usually originates from the replacement of the catalytic serine or tyrosine residues in the active site motif by a cysteinyl residue as demonstrated for mammalian, insect and fungal Omega GSTs (GSTOs) (Board et al., 2006
Cases of severe reactions 1
Class: Combination of BPC-157 (pentadecapeptide) and TB-500 (Thymosin 4 fragment)
Fukada T, Civic N, Furuichi T, Shimoda S, Mishima K, Higashiyama H, et al
Postsupplement comparisons are shown as OAG- 0w vs OAG-16w, OAP-0w vs OAP-16w, and as OAG-16w vs YA-0w and OAP-16w vs YA-0w